THE ADVANCES INITIATIVE: New Advances in Headache Diagnosis and Treatment

View Activity


Dawn C. Buse, PhD
Director of Behavioral Medicine
Montefiore Headache Center
Professor, Department of Neurology
Albert Einstein College of Medicine of Yeshiva University
Assistant Professor, Clinical Health Psychology Doctoral
Program Ferkauf Graduate School of Psychology of Yeshiva University
New York, NY


This online activity is focused on the early diagnosis and management of migraine.


This activity is intended for neurologists, PCPs, and headache specialists involved in managing patients with headache and migraine issues.


After completing the CME activity, learners should be better able to:

  • Discuss the prevalence, pathophysiology, epidemiology, and burden of illness associated with migraine;
  • Describe the diagnostic approach to primary headache disorders, with an emphasis on migraine and cluster headache, including differential diagnosis from other conditions causing headache;
  • Discuss the established acute and preventive therapeutic options for patients with migraine; and
  • Describe publicly available safety and efficacy findings from recent clinical trials investigating novel therapies for the management of migraine.


Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.


Purpose: This program would be beneficial for nurses involved in the care of patients with headache and migraine issues. Credits: 1.0 ANCC Contact Hours.

CNE Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.0 contact hours of continuing nursing education of RNs and APNs.


Amedco is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Successful completion of this program qualifies for up to 1 contact hours. Full attendance is required. No partial contact hours will be awarded for partial attendance. UAN: 0453-9999-17-505-H04-P(K)


This program has been reviewed and is approved for a maximum 1.00 AAPA Category 1 CME credits by the AAPA Review Panel. Pas should claim only the credit commensurate with the extent of their participation in the activity. This program was planned in accordance with the AAPA CME Standards for Live Programs and for Commercial Support of Live Programs.


The American Osteopathic Association (AOA) Council on Continuing Medical Education has APPROVED this activity for 1 AOA Category 2‐B credits.


In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG‐sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.


Dawn C. Buse, PhD, has received consulting fees from Allergan, Amgen, Avanir Pharmaceuticals, Biohaven, Eli Lilly, and Promius Pharma, LLC. Dr. Buse has conducted research Allergan, Amgen, Avanir Pharmaceuticals, and Promius Pharma, LLC.

CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
UMA/CCM nurse Reviewer ‐ ‐ Barbara OBrien, RN has nothing to disclose.

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Lisa Crenshaw, Senior Program Manager for Med Learning Group, has nothing to disclose.
Ana Maria Albino, Program Manager for Med Learning Group, has nothing to disclose.
Flavia Piazza, PhD, VP Medical and Scientific Services for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.


Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During the course of this lecture, the faculty may mention the use of medications for both FDA‐approved and non‐ approved indications.

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:

1. Read the CME/CNE information and faculty disclosures.
2. Participate in the enduring activity.
3. Submit the evaluation form to the Med Learning Group.

You will receive your certificate via email within 30 days.


Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact: Med Learning Group at

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at:

RELEASE DATE: November 29, 2017

EXPIRATION DATE: November 29, 2018

View Activity

Participation Statement
This educational activity provides training necessary for licensed attendees to maintain state licensing requirements. The tuition for this educational activity is subsidized in part by unrestricted educational grants, including for those attendees who have successfully completed the state licensing requirements for their respective fields. This subsidy is reflected in the registration fees for this activity.

Copyright © 2017 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.